Latest Schedule 13G passive stakes

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 7.3% of RxSight, Inc. common stock.

Seven Fleet Horizon Master Fund LP, Seven Fleet Master Fund LP, Seven Fleet Capital Management LP, Seven Fleet Capital Management GP LLC, and Brian Liu have collectively reported a change in their beneficial ownership of Entera Bio, Ltd. ordinary shares.

Ascent Partners Fund LLC and affiliated entities now hold a 9.99% beneficial ownership stake in Our Bond, Inc., triggering a Schedule 13G filing.

Ascent Partners Fund LLC and affiliated entities report a 9.99% beneficial ownership in Profusa, Inc. common stock, including shares from convertible notes and a securities purchase agreement, subject to a beneficial ownership limitation.

Laurion Capital Management LP and associated individuals report beneficial ownership of 6.06% of Immunic, Inc.'s common stock, including shares issuable from warrants.

UBS Group AG has filed a Schedule 13G, reporting beneficial ownership of 5.45% of Rising Dragon Acquisition Corp.'s common stock.

UBS Group AG has filed a Schedule 13G, reporting beneficial ownership of 5.45% of Rising Dragon Acquisition Corp.'s common stock.

Boston Partners has reported a beneficial ownership of 6.66% in DoubleDown Interactive Co., Ltd. American Depository Shares, representing 165,051 ADSs.

Boston Partners has disclosed beneficial ownership of 5.9% of Cytek Biosciences, Inc. common stock as of June 30, 2026.

Citadel entities, including Citadel Securities and Kenneth Griffin, have reported beneficial ownership of FuelCell Energy shares, totaling 3.8% and 2.7% for certain entities.

Radoff Family Foundation and Bradley L. Radoff have disclosed an aggregate beneficial ownership of 10.4% in Regional Health Properties, Inc., signaling increased investor interest.

UBS Group AG has filed a Schedule 13G detailing its beneficial ownership of Starlink AI Acquisition Corp units, holding 5.4% of the class.

UBS Group AG has filed a Schedule 13G detailing its beneficial ownership of Starlink AI Acquisition Corp units, holding 5.4% of the class.

Boston Partners has reported a beneficial ownership of 6.66% in DoubleDown Interactive Co., Ltd. American Depository Shares, as of June 30, 2026.

Boston Partners has reported beneficial ownership of 4,004,971.6 shares, representing 5.01% of LPL Financial Holdings Inc.'s common stock, as of June 30, 2026.

Boston Partners has disclosed a beneficial ownership stake of 5.31% in Methanex Corp, holding over 4.1 million shares as of June 30, 2026.

TCG Crossover Fund III, L.P., TCG Crossover GP III, LLC, and Chen Yu have jointly filed a Schedule 13G, reporting beneficial ownership of 12,254,901 ordinary shares, representing 7.1% of Entera Bio Ltd.'s outstanding shares.

ClearPoint Neuro, Inc. has filed an amendment to its Schedule 13G, detailing updated beneficial ownership information as of June 30, 2026.

Jane Street Group, LLC and its affiliates have reported a combined beneficial ownership of 5.1% in Bloom Energy Corp, indicating a significant position held by the financial entity.

Alpha Capital Anstalt has filed a Schedule 13G, reporting beneficial ownership of 559,394 shares, representing 8.41% of Fabric.AI, Inc.'s common stock.

Van Berkom & Associates Inc. has disclosed beneficial ownership of 2,969,220 common shares, representing 5.97% of Stevanato Group S.p.A., as of June 30, 2026.

Squadron Master Fund LP, along with its investment advisor Squadron Capital Management LLC and key individuals, has reported beneficial ownership of 5.6% of Quince Therapeutics, Inc. common stock.

Streeterville Capital LLC and affiliates have filed a Schedule 13G, reporting beneficial ownership of 1,437,361 shares, representing 9.99% of Game Your Game Inc.'s common stock, subject to a contractual ownership cap.

Boston Partners has disclosed beneficial ownership of 4,470,225.3 shares, representing 6.44% of the outstanding common stock of Cactus, Inc., as of June 30, 2026.

Several Vivo Opportunity entities have updated their beneficial ownership filings for Entera Bio Ltd., reflecting significant holdings and voting power.

Streeterville Capital LLC and affiliated entities have reported a beneficial ownership of 487,171 shares, representing 9.99% of Alpha Modus Holdings, Inc.'s Class A common stock, subject to a contractual cap.

Boston Partners has reported a beneficial ownership of 2,595,084 shares, representing 5.45% of Zebra Technologies Corp.'s common stock as of June 30, 2026.

Logos Global Management LP and affiliated entities have reported beneficial ownership of 9.9% of Yarrow Bioscience, Inc. common stock, including shares and pre-funded warrants.

Copeland Capital Management, LLC has increased its beneficial ownership of U.S. Physical Therapy Inc. common stock to 5.53%, holding 841,544 shares.

Copeland Capital Management, LLC has reported a beneficial ownership of 5.65% in NAPCO Security Technologies, Inc. common stock as of June 30, 2026.